Filing Details
- Accession Number:
- 0001209191-22-038432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-06-21 16:37:17
- Reporting Period:
- 2022-06-16
- Accepted Time:
- 2022-06-21 16:37:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1654151 | Deciphera Pharmaceuticals Inc. | DCPH | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1325710 | L Matthew Sherman | C/O Deciphera Pharmaceuticals, Inc. 200 Smith Street Waltham MA 02451 | Evp & Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-06-16 | 1,768 | $10.75 | 76,884 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- This sale was to cover tax liabilities in the vesting of restricted stock.
- Includes 1,862 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 14, 2022.
Billionaire Hedge Funds
